| Product Code: ETC6546544 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Bulgaria`s import of deoxyribonucleic acid (DNA) and gene chip (microarrays) in 2024 continued to be dominated by top exporters such as Italy, USA, Sweden, Germany, and the UK. The Market Top 5 Importing Countries and Market Competition (HHI) Analysis concentration, as measured by the Herfindahl-Hirschman Index (HHI), reached very high levels in 2024, indicating a significant level of concentration among these countries. Despite a high compound annual growth rate (CAGR) of 20.01% from 2020 to 2024, the growth rate saw a sharp decline of -79.06% from 2023 to 2024, signaling potential shifts in Market Top 5 Importing Countries and Market Competition (HHI) Analysis dynamics or temporary disruptions in the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Overview |
3.1 Bulgaria Country Macro Economic Indicators |
3.2 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, 2022 & 2032F |
3.3 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Industry Life Cycle |
3.4 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Porter's Five Forces |
3.5 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.7 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on precision medicine and personalized healthcare |
4.2.2 Growing demand for genetic testing and diagnostics |
4.2.3 Technological advancements in DNA sequencing and microarray technologies |
4.3 Market Restraints |
4.3.1 High cost associated with DNA and gene chip technologies |
4.3.2 Limited awareness and adoption of these technologies in Bulgaria |
4.3.3 Regulatory challenges related to genetic testing and data privacy |
5 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Trends |
6 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Types |
6.1 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Consumables, 2022 - 2032F |
6.1.4 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Instrumentation, 2022 - 2032F |
6.2 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Oligonucleotide DNA Microarrays (oDNA), 2022 - 2032F |
6.2.3 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Complementary DNA Microarrays (cDNA), 2022 - 2032F |
6.3 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Gene Expression, 2022 - 2032F |
6.3.3 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Cancer Diagnosticsand Treatments, 2022 - 2032F |
6.3.4 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Drug Discovery, 2022 - 2032F |
6.3.5 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Genetics, 2022 - 2032F |
6.3.6 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By SNP Analysis, 2022 - 2032F |
6.3.7 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Screening and Monitoring Of Patient Data DuringClinical Trials, 2022 - 2032F |
6.3.8 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Other, 2022 - 2032F |
6.3.9 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Other, 2022 - 2032F |
6.4 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Academic and Research Institutes, 2022 - 2032F |
6.4.3 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Biotechnological and Pharmaceutical Companies, 2022 - 2032F |
6.4.4 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Research Laboratories, 2022 - 2032F |
7 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Import-Export Trade Statistics |
7.1 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Export to Major Countries |
7.2 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Imports from Major Countries |
8 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Key Performance Indicators |
8.1 Rate of adoption of DNA and gene chip technologies in healthcare facilities |
8.2 Number of research studies and clinical trials utilizing DNA and gene chip technologies |
8.3 Investment in RD for developing new DNA and gene chip products |
8.4 Percentage of healthcare professionals trained in interpreting DNA and gene chip data |
8.5 Number of partnerships and collaborations between technology providers and healthcare institutions for DNA and gene chip applications |
9 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Opportunity Assessment |
9.1 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Type, 2022 & 2032F |
9.3 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Competitive Landscape |
10.1 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenue Share, By Companies, 2025 |
10.2 Bulgaria Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here